These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5128 related articles for article (PubMed ID: 3656364)

  • 1. Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
    Boger DL; Yasuda M; Mitscher LA; Drake SD; Kitos PA; Thompson SC
    J Med Chem; 1987 Oct; 30(10):1918-28. PubMed ID: 3656364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis of novel 6-substituted lavendamycin antitumor agents.
    Seradj H; Cai W; Erasga NO; Chenault DV; Knuckles KA; Ragains JR; Behforouz M
    Org Lett; 2004 Feb; 6(4):473-6. PubMed ID: 14961601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones.
    Behforouz M; Cai W; Mohammadi F; Stocksdale MG; Gu Z; Ahmadian M; Baty DE; Etling MR; Al-Anzi CH; Swiftney TM; Tanzer LR; Merriman RL; Behforouz NC
    Bioorg Med Chem; 2007 Jan; 15(1):495-510. PubMed ID: 17035024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siloxane-based cross-coupling of bromopyridine derivatives: studies for the synthesis of streptonigrin and lavendamycin.
    McElroy WT; DeShong P
    Org Lett; 2003 Dec; 5(25):4779-82. PubMed ID: 14653672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteroaryl cross-coupling as an entry toward the synthesis of lavendamycin analogues: a model study.
    Verniest G; Wang X; De Kimpe N; Padwa A
    J Org Chem; 2010 Jan; 75(2):424-33. PubMed ID: 20017470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.
    Cai W; Hassani M; Karki R; Walter ED; Koelsch KH; Seradj H; Lineswala JP; Mirzaei H; York JS; Olang F; Sedighi M; Lucas JS; Eads TJ; Rose AS; Charkhzarrin S; Hermann NG; Beall HD; Behforouz M
    Bioorg Med Chem; 2010 Mar; 18(5):1899-909. PubMed ID: 20149966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quinoline quinone as the minimum entity for reverse transcriptase inhibitory activity of streptonigrin.
    Inouye Y; Take Y; Oogose K; Kubo A; Nakamura S
    J Antibiot (Tokyo); 1987 Jan; 40(1):105-7. PubMed ID: 2435693
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel lavendamycin analogues as potent HIV-reverse transcriptase inhibitors: synthesis and evaluation of anti-reverse transcriptase activity of amide and ester analogues of lavendamycin.
    Behforouz M; Cai W; Stocksdale MG; Lucas JS; Jung JY; Briere D; Wang A; Katen KS; Behforouz NC
    J Med Chem; 2003 Dec; 46(26):5773-80. PubMed ID: 14667230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptonigrin and related compounds. 5. Synthesis and evaluation of some isoquinoline analogues.
    Rao KV; Beach JW
    J Med Chem; 1991 Jun; 34(6):1871-9. PubMed ID: 1905760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of lavendamycin, a new antibiotic from Streptomyces lavendulae.
    Balitz DM; Bush JA; Bradner WT; Doyle TW; O'Herron FA; Nettleton DE
    J Antibiot (Tokyo); 1982 Mar; 35(3):259-65. PubMed ID: 7076573
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel cytocidal compounds, oxopropalines from Streptomyces sp. G324 producing lavendamycin. II. Physico-chemical properties and structure elucidations.
    Abe N; Enoki N; Nakakita Y; Uchida H; Nakamura T; Munekata M
    J Antibiot (Tokyo); 1993 Nov; 46(11):1678-86. PubMed ID: 8270489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the cytotoxic activities of novel analogues of the antitumor agent, lavendamycin.
    Fang Y; Linardic CM; Richardson DA; Cai W; Behforouz M; Abraham RT
    Mol Cancer Ther; 2003 Jun; 2(6):517-26. PubMed ID: 12813130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cytocidal compounds, oxopropalines from Streptomyces sp. G324 producing lavendamycin. I. Taxonomy of the producing organism, fermentation, isolation and biological activities.
    Abe N; Nakakita Y; Nakamura T; Enoki N; Uchida H; Takeo S; Munekata M
    J Antibiot (Tokyo); 1993 Nov; 46(11):1672-7. PubMed ID: 8270488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of bruneomycin formed by Act. albus var. bruneomycini and its identification with streptonigrin].
    Brazhnikova MG; Ponomarenko VI; Kovsharova IN; Krugliak EB; Proshliakova VV
    Antibiotiki; 1968 Feb; 13(2):99-102. PubMed ID: 4970063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
    Shorin VA; Bazhanov VS
    Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
    [No Abstract]   [Full Text] [Related]  

  • 16. Transformation of streptonigrin into streptonigrone; synthesis and biological evaluation of antibiotics streptonigrin and streptonigrone alkyl ethers.
    Preobrazhenskaya MN; Holpne-Kozlova NV; Lazhko EI
    J Antibiot (Tokyo); 1992 Feb; 45(2):227-34. PubMed ID: 1556014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies related to antitumor antibiotics. Part VIII. Cleavage of DNA by streptonigrin analogues and the relationship to antineoplastic activity.
    Lown JW; Sim SK
    Can J Biochem; 1976 May; 54(5):446-52. PubMed ID: 1276971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
    Dreyton CJ; Anderson ED; Subramanian V; Boger DL; Thompson PR
    Bioorg Med Chem; 2014 Feb; 22(4):1362-9. PubMed ID: 24440480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ring D in the antitumour antibiotic streptonigrin: metal complexation, DNA binding and topoisomerase inhibition by ABC ring analogues of streptonigrin.
    Anderberg PI; Harding MM
    Anticancer Drug Des; 2001; 16(2-3):143-53. PubMed ID: 11962512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1.
    Hassani M; Cai W; Holley DC; Lineswala JP; Maharjan BR; Ebrahimian GR; Seradj H; Stocksdale MG; Mohammadi F; Marvin CC; Gerdes JM; Beall HD; Behforouz M
    J Med Chem; 2005 Dec; 48(24):7733-49. PubMed ID: 16302813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 257.